DK2231633T3 - Antitumorale forbindelser - Google Patents

Antitumorale forbindelser

Info

Publication number: DK2231633T3
Authority: DK; Denmark
Prior art keywords: antitumoral; relations; cancer; compound; treatment
Prior art date: 2007-12-20

Application number

DK08864895.1T

Other languages

English (en)

Inventor

Vicente Alberto Rodriguez

Garcia-Ibarrola Maria Garranzo

Perez Carmen Murcia

Sancho Francisco Sanchez

Marchante Maria Del Carmen Cuevas

Urbano Cristina Mateo

Juarez Isabel Digon

Original Assignee

Pharma Mar Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-20

Filing date

2008-12-19

Publication date

2014-01-20

2008-12-19 Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa

2014-01-20 Application granted granted Critical

2014-01-20 Publication of DK2231633T3 publication Critical patent/DK2231633T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

DK08864895.1T 2007-12-20 2008-12-19 Antitumorale forbindelser DK2231633T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07123882		2007-12-20
PCT/EP2008/068049 WO2009080761A1 (en)	2007-12-20	2008-12-19	Antitumoral compounds

Publications (1)

Publication Number	Publication Date
DK2231633T3 true DK2231633T3 (da)	2014-01-20

Family

ID=40580474

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK08865009.8T DK2231590T3 (da)	2007-12-20	2008-12-19	Antitumorforbindelser
DK08864895.1T DK2231633T3 (da)	2007-12-20	2008-12-19	Antitumorale forbindelser

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK08865009.8T DK2231590T3 (da)	2007-12-20	2008-12-19	Antitumorforbindelser

Country Status (27)

Country	Link
US (4)	US9187445B2 (da)
EP (3)	EP2231633B1 (da)
JP (3)	JP5529038B2 (da)
KR (3)	KR101639772B1 (da)
CN (4)	CN102190643B (da)
AT (1)	ATE549313T1 (da)
AU (2)	AU2008341670B2 (da)
BR (2)	BRPI0821116B8 (da)
CA (2)	CA2710087C (da)
CY (1)	CY1117245T1 (da)
DK (2)	DK2231590T3 (da)
ES (3)	ES2384420T3 (da)
HK (3)	HK1180678A1 (da)
HR (2)	HRP20120464T1 (da)
IL (3)	IL206396A (da)
MX (2)	MX2010006796A (da)
MY (3)	MY148651A (da)
NZ (3)	NZ586013A (da)
PL (2)	PL2231590T3 (da)
PT (2)	PT2231633E (da)
RS (2)	RS52343B (da)
RU (3)	RU2528393C9 (da)
SG (2)	SG170778A1 (da)
SI (2)	SI2231590T1 (da)
UA (3)	UA104281C2 (da)
WO (2)	WO2009080761A1 (da)
ZA (3)	ZA201004018B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2231590T3 (da)	2007-12-20	2012-07-09	Pharma Mar Sa	Antitumorforbindelser
JP6180115B2 (ja) *	2012-01-05	2017-08-16	花王株式会社	刺激感緩和剤
PL2986607T3 (pl)	2013-04-16	2017-11-30	Idorsia Pharmaceuticals Ltd	Przeciwbakteryjne pochodne biaromatyczne
GB201309807D0 (en) *	2013-05-31	2013-07-17	Pharma Mar Sau	Antibody drug conjugates
CN108467378A (zh) *	2017-02-23	2018-08-31	复旦大学	一种二氢吡喃酮类化合物及其制备方法和用途
JOP20190254A1 (ar)	2017-04-27	2019-10-27	Pharma Mar Sa	مركبات مضادة للأورام

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5142056A (en) *	1989-05-23	1992-08-25	Abbott Laboratories	Retroviral protease inhibiting compounds
US4855086A (en) *	1982-10-15	1989-08-08	Burroughs Wellcome Co.	Novel pesticides, preparation and use
JPS61109717A (ja)	1984-11-02	1986-05-28	Teruhiko Beppu	抗腫瘍剤
EP0564561A4 (en) *	1990-12-28	1994-08-10	Georgia Tech Res Inst	Peptides ketoamides, ketoacids, and ketoesters
JPH0539283A (ja)	1991-01-31	1993-02-19	Suntory Ltd	新規物質Ｓ−５９９１７ａ及びその製造方法
ZA938019B (en)	1992-11-13	1995-04-28	Upjohn Co	Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
US5523456A (en) *	1994-09-29	1996-06-04	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US5681847A (en) *	1995-12-05	1997-10-28	Harbor Branch Oceanographic Institution, Inc.	Methods of using discodermolide compounds
US5834506A (en)	1996-11-01	1998-11-10	Warner-Lambert Company	Dihydropyrones with improved antiviral activity
US5840974A (en) *	1996-12-04	1998-11-24	Britisch Biotech Pharmaceuticals, Ltd.	Metalloproteinase inhibitors
AU773567B2 (en)	1998-09-11	2004-05-27	Warner-Lambert Company	HIV protease inhibitors
US6380400B1 (en)	1998-09-11	2002-04-30	Victor Fedij	Methods of making dihydropyrone HIV protease inhibitors
CA2401104A1 (en) *	2000-04-04	2001-10-11	Novartis Ag	Method for treating cells resistant to antineoplastic agents
EP2082737B1 (en) *	2002-03-04	2014-12-31	Merck HDAC Research, LLC	Methods of inducing terminal differentiation
AU2004263287B2 (en)	2003-07-25	2009-02-12	Novartis Ag	Substituted lactams and their use as anti-cancer agents
US7446196B2 (en)	2004-06-03	2008-11-04	Kosan Biosciences, Incorporated	Leptomycin compounds
RU2006142690A (ru) *	2004-06-03	2008-06-10	Козан Байосайенсиз Инкорпорейтед (Us)	Соединения лептомицина
WO2007014423A1 (en) *	2005-08-02	2007-02-08	Medvet Science Pty, Ltd.	Exercise apparatus
NZ573706A (en)	2006-06-16	2011-09-30	Pharma Mar Sa	Antitumoral dihydropyran-2-one compounds
DK2231590T3 (da)	2007-12-20	2012-07-09	Pharma Mar Sa	Antitumorforbindelser

2008
- 2008-12-19 DK DK08865009.8T patent/DK2231590T3/da active
- 2008-12-19 CN CN201110073931.0A patent/CN102190643B/zh active Active
- 2008-12-19 NZ NZ586013A patent/NZ586013A/en unknown
- 2008-12-19 CN CN200880121840.6A patent/CN101903367B/zh active Active
- 2008-12-19 CN CN2011100568656A patent/CN102174058A/zh active Pending
- 2008-12-19 BR BRPI0821116A patent/BRPI0821116B8/pt active IP Right Grant
- 2008-12-19 ES ES08865009T patent/ES2384420T3/es active Active
- 2008-12-19 AU AU2008341670A patent/AU2008341670B2/en active Active
- 2008-12-19 SI SI200830644T patent/SI2231590T1/sl unknown
- 2008-12-19 CA CA2710087A patent/CA2710087C/en active Active
- 2008-12-19 ES ES08864895.1T patent/ES2442140T3/es active Active
- 2008-12-19 MY MYPI2010002590A patent/MY148651A/en unknown
- 2008-12-19 RS RS20120242A patent/RS52343B/en unknown
- 2008-12-19 DK DK08864895.1T patent/DK2231633T3/da active
- 2008-12-19 SI SI200831122T patent/SI2231633T1/sl unknown
- 2008-12-19 KR KR1020157016575A patent/KR101639772B1/ko active IP Right Grant
- 2008-12-19 MX MX2010006796A patent/MX2010006796A/es active IP Right Grant
- 2008-12-19 ES ES13154647.5T patent/ES2578606T3/es active Active
- 2008-12-19 WO PCT/EP2008/068049 patent/WO2009080761A1/en active Application Filing
- 2008-12-19 MX MX2010006795A patent/MX2010006795A/es active IP Right Grant
- 2008-12-19 JP JP2010538765A patent/JP5529038B2/ja active Active
- 2008-12-19 RU RU2013112003/04A patent/RU2528393C9/ru active
- 2008-12-19 AU AU2008341671A patent/AU2008341671B2/en active Active
- 2008-12-19 UA UAA201009035A patent/UA104281C2/ru unknown
- 2008-12-19 MY MYPI2010002591A patent/MY155342A/en unknown
- 2008-12-19 RS RS20140007A patent/RS53140B/en unknown
- 2008-12-19 US US12/746,974 patent/US9187445B2/en active Active
- 2008-12-19 BR BRPI0821114A patent/BRPI0821114B8/pt active IP Right Grant
- 2008-12-19 SG SG201102163-1A patent/SG170778A1/en unknown
- 2008-12-19 PL PL08865009T patent/PL2231590T3/pl unknown
- 2008-12-19 WO PCT/EP2008/068065 patent/WO2009080769A1/en active Application Filing
- 2008-12-19 JP JP2010538769A patent/JP5727228B2/ja active Active
- 2008-12-19 NZ NZ586012A patent/NZ586012A/en unknown
- 2008-12-19 PL PL08864895T patent/PL2231633T3/pl unknown
- 2008-12-19 EP EP08864895.1A patent/EP2231633B1/en active Active
- 2008-12-19 PT PT88648951T patent/PT2231633E/pt unknown
- 2008-12-19 AT AT08865009T patent/ATE549313T1/de active
- 2008-12-19 EP EP08865009A patent/EP2231590B9/en active Active
- 2008-12-19 UA UAA201009034A patent/UA106967C2/uk unknown
- 2008-12-19 RU RU2010130253/04A patent/RU2489429C2/ru active
- 2008-12-19 CA CA2715203A patent/CA2715203C/en active Active
- 2008-12-19 KR KR1020107015968A patent/KR101579553B1/ko active IP Right Grant
- 2008-12-19 NZ NZ597526A patent/NZ597526A/en unknown
- 2008-12-19 EP EP13154647.5A patent/EP2597091B1/en active Active
- 2008-12-19 US US12/746,966 patent/US8710264B2/en active Active
- 2008-12-19 UA UAA201406894A patent/UA119963C2/uk unknown
- 2008-12-19 RU RU2010130180/04A patent/RU2493147C2/ru active
- 2008-12-19 MY MYPI2014002392A patent/MY164533A/en unknown
- 2008-12-19 SG SG201102164-9A patent/SG170779A1/en unknown
- 2008-12-19 KR KR1020107015965A patent/KR101541436B1/ko active IP Right Grant
- 2008-12-19 PT PT08865009T patent/PT2231590E/pt unknown
- 2008-12-19 CN CN2008801218410A patent/CN101903337B/zh active Active
2010
- 2010-06-04 ZA ZA2010/04018A patent/ZA201004018B/en unknown
- 2010-06-04 ZA ZA2010/04017A patent/ZA201004017B/en unknown
- 2010-06-15 IL IL206396A patent/IL206396A/en active IP Right Grant
- 2010-06-15 IL IL206397A patent/IL206397A/en active IP Right Grant
2011
- 2011-03-01 HK HK13107821.5A patent/HK1180678A1/zh unknown
- 2011-03-01 HK HK11102050.0A patent/HK1147990A1/xx unknown
- 2011-03-01 HK HK11102052.8A patent/HK1147998A1/xx unknown
- 2011-08-31 ZA ZA2011/06371A patent/ZA201106371B/en unknown
2012
- 2012-06-01 HR HRP20120464AT patent/HRP20120464T1/hr unknown
2013
- 2013-11-24 IL IL229594A patent/IL229594A/en active IP Right Grant
2014
- 2014-01-08 HR HRP20140015AT patent/HRP20140015T1/hr unknown
- 2014-01-27 CY CY20141100069T patent/CY1117245T1/el unknown
- 2014-04-10 JP JP2014080887A patent/JP5860088B2/ja active Active
2015
- 2015-08-12 US US14/824,699 patent/US9827257B2/en active Active
- 2015-08-12 US US14/824,690 patent/US9750759B2/en active Active

Also Published As

Publication number	Publication date
ZA201004018B (en)	2011-12-28
EP2231590B1 (en)	2012-03-14
IL206396A0 (en)	2010-12-30
US8710264B2 (en)	2014-04-29
RU2013112003A (ru)	2014-08-20
CN102190643A (zh)	2011-09-21
PT2231633E (pt)	2014-01-20
WO2009080769A1 (en)	2009-07-02
HRP20140015T1 (hr)	2014-02-14
MY155342A (en)	2015-10-15
ES2384420T3 (es)	2012-07-04
US20110034549A1 (en)	2011-02-10
ZA201004017B (en)	2011-12-28
PT2231590E (pt)	2012-06-25
SI2231590T1 (sl)	2012-10-30
RU2010130180A (ru)	2012-01-27
CY1117245T1 (el)	2017-04-05
KR101579553B1 (ko)	2015-12-22
RU2489429C2 (ru)	2013-08-10
UA106967C2 (uk)	2014-11-10
US20150342972A1 (en)	2015-12-03
JP2011506575A (ja)	2011-03-03
IL206396A (en)	2014-05-28
IL206397A0 (en)	2010-12-30
AU2008341670B2 (en)	2012-04-19
US20120041063A2 (en)	2012-02-16
EP2597091B1 (en)	2016-04-20
EP2231590A1 (en)	2010-09-29
PL2231633T3 (pl)	2014-03-31
IL206397A (en)	2014-01-30
US9750759B2 (en)	2017-09-05
RS52343B (en)	2012-12-31
IL229594A (en)	2016-02-29
SG170779A1 (en)	2011-05-30
PL2231590T3 (pl)	2012-09-28
SI2231633T1 (sl)	2014-02-28
CA2710087A1 (en)	2009-07-02
MX2010006795A (es)	2010-10-26
ES2578606T3 (es)	2016-07-28
UA119963C2 (uk)	2019-09-10
MY148651A (en)	2013-05-15
BRPI0821114B1 (pt)	2021-09-08
BRPI0821116B1 (pt)	2020-02-18
BRPI0821114B8 (pt)	2021-11-09
CN101903367A (zh)	2010-12-01
BRPI0821116A2 (pt)	2015-08-11
JP5529038B2 (ja)	2014-06-25
JP2011506578A (ja)	2011-03-03
KR101639772B1 (ko)	2016-07-15
ZA201106371B (en)	2013-05-29
JP5860088B2 (ja)	2016-02-16
US9827257B2 (en)	2017-11-28
CN102190643B (zh)	2015-02-25
KR101541436B1 (ko)	2015-08-03
RS53140B (en)	2014-06-30
EP2231590B9 (en)	2012-08-15
RU2528393C1 (ru)	2014-09-20
HRP20120464T1 (hr)	2012-07-31
BRPI0821114A2 (pt)	2015-06-16
RU2010130253A (ru)	2012-01-27
ATE549313T1 (de)	2012-03-15
CA2715203C (en)	2015-09-08
EP2231633B1 (en)	2013-10-30
JP2014133752A (ja)	2014-07-24
NZ586013A (en)	2012-02-24
AU2008341671B2 (en)	2012-07-26
MY164533A (en)	2017-12-29
SG170778A1 (en)	2011-05-30
BRPI0821116B8 (pt)	2021-05-25
CN102174058A (zh)	2011-09-07
HK1180678A1 (zh)	2013-10-25
CN101903367B (zh)	2015-08-05
KR20150076265A (ko)	2015-07-06
HK1147998A1 (en)	2011-08-26
CA2715203A1 (en)	2009-07-02
US9187445B2 (en)	2015-11-17
RU2493147C2 (ru)	2013-09-20
JP5727228B2 (ja)	2015-06-03
AU2008341670A1 (en)	2009-07-02
NZ586012A (en)	2011-11-25
US20100280108A1 (en)	2010-11-04
CN101903337B (zh)	2013-12-18
DK2231590T3 (da)	2012-07-09
EP2597091A1 (en)	2013-05-29
ES2442140T3 (es)	2014-02-25
AU2008341671A1 (en)	2009-07-02
CA2710087C (en)	2015-06-02
US20150344454A1 (en)	2015-12-03
KR20100125226A (ko)	2010-11-30
MX2010006796A (es)	2010-10-26
KR20100100979A (ko)	2010-09-15
NZ597526A (en)	2012-06-29
IL229594A0 (en)	2014-01-30
UA104281C2 (ru)	2014-01-27
WO2009080761A1 (en)	2009-07-02
CN101903337A (zh)	2010-12-01
HK1147990A1 (en)	2011-08-26
EP2231633A1 (en)	2010-09-29
RU2528393C9 (ru)	2015-01-10

Publication	Publication Date	Title
NL300936I2 (nl)	2018-08-07	Semaglutide
EA200801428A1 (ru)	2008-10-30	Производные пиридиазинона для лечения опухолей
GEP20125702B (en)	2012-12-10	Benzimidazole derivatives
IL229594A0 (en)	2014-01-30	Materials and preparations for the treatment of tumors
NO20081292L (no)	2008-05-13	Pentasykliske kinaseinhibitorer
EA200901179A1 (ru)	2010-04-30	Замещённые тетрагидрохинолины
MY159479A (en)	2017-01-13	Herbicides
WO2010149688A3 (en)	2011-08-25	Antitumoral compounds
HRP20120434T1 (en)	2012-06-30	4-oxadiazolyl-piperidine compounds and use thereof
GB0620005D0 (en)	2006-11-22	Compounds